Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012

Aims In heart failure with reduced ejection fraction, drug and device therapy improve survival. We studied contemporary trends in utilization of evidence‐based therapy and associated survival. Methods and results We studied 5908 patients with NYHA class II–IV heart failure, EF

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of heart failure 2016-05, Vol.18 (5), p.503-511
Hauptverfasser:	Thorvaldsen, Tonje, Benson, Lina, Dahlström, Ulf, Edner, Magnus, Lund, Lars H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - therapeutic use Aged Aged, 80 and over Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Cardiac Resynchronization Therapy Defibrillators, Implantable Evidence-Based Medicine Evidence-based therapy Female Guidelines Heart failure Heart Failure - therapy Humans Implementation Male Middle Aged Mineralocorticoid Receptor Antagonists - therapeutic use Outcomes Registries Survival Rate Sweden Utilization
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Aims In heart failure with reduced ejection fraction, drug and device therapy improve survival. We studied contemporary trends in utilization of evidence‐based therapy and associated survival. Methods and results We studied 5908 patients with NYHA class II–IV heart failure, EF
ISSN:	1388-9842 1879-0844 1879-0844
DOI:	10.1002/ejhf.496